Clinical Trial Update: Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET [Phase 3]

View source ↗

Summary

A Phase 3 clinical study update evaluating recombinant human follitropin for injection used for controlled ovarian hyperstimulation in assisted reproduction (IV…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility
• Ovarian Hyperstimulation Syndrome

Drugs mentioned

• recombinant human follitropin for injection (recombinant human follicle-stimulating hormone (rFSH))

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Ovarian Hyperstimulation Syndrome | Phase 3 | Status: UNKNOWN